Liposomes Market, By Type (Conventional Liposomes, PEGylated Liposomes, Ligand-Targeted Liposomes, Long-Circulating (Stealth) Liposomes, pH-Sensitive Liposomes, Temperature-Sensitive Liposomes, and Cationic Liposomes), By Structure (Multilamellar Vesicles, Small Unilamellar Vesicles, Large Unilamellar Vesicles, and Giant Unilamellar Vesicles), By Lipid Composition (Phospholipid-Based Liposomes, Cholesterol-Enriched Liposomes, Sphingomyelin-Based Liposomes, Synthetic Lipid Liposomes (DSPC, DOPC, others), and Natural Lipid Liposomes), By Technique of Preparation (Thin Film Hydration, Reverse-Phase Evaporation, Ethanol Injection, Microfluidics-Based Production, Detergent Removal, Freeze–Thaw Method, and High-Pressure Homogenization), By Drug Loading Method (Passive Loading and Active Loading (pH Gradient, Ammonium Sulfate Gradient)), By Application (Drug Delivery, Oncology, Infectious Diseases, Cardiovascular Diseases, Neurological Disorders, Dermatology, Gene Delivery, Vaccine Delivery, Cosmetics and Personal Care, Nutraceuticals, and Diagnostics and Imaging), By Route of Administration (Intravenous, Intramuscular, Subcutaneous, Oral, Topical, and Inhalation), By End User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, Hospitals and Clinics, Cosmetics and Personal Care Manufacturers, and Contract Research and Manufacturing Organizations (CROs/CMOs)), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) - Growth Trends and Forecasts (2025-2032)